Leg stretches may reduce pain in patients with PAD
Click Here to Manage Email Alerts
Patients with peripheral artery disease who stretched before walking experienced decreased pain, according to an abstract presented at the American Heart Association’s Arteriosclerosis, Thrombosis and Vascular Biology/Peripheral Vascular Disease Scientific Sessions.
“This is a very safe, easy intervention that can be done at home and has the potential to really improve your tolerance for walking and get you into a walking program,” Judy M. Muller-Delp, PhD, professor of biomedical sciences at the Florida State University College of Medicine in Tallahassee, said in a press release.
Researchers assessed blood flow and walking ability in 13 patients (mean age, 71 years; seven men) with PAD. Patients stretched each leg for a half-hour 5 days per week for 4 weeks, then stopped stretching for 4 weeks. Most patients were taking antiplatelet medications and a statin.
After 4 weeks of stretching, compared with the period after 4 weeks of not stretching, patients’ 6-minute walking distance (355 ± 32 m vs. 311 ± 31 m; P = .007) and flow-mediated dilation (5.2 ± 0.6% vs. 3.7 ± 0.4%; P = .003) improved. Researchers did not observe a difference in nitroglycerin-induced dilation between stretching (10.9 ± 1.4%) and no stretching (9.9 ± 1.1%; P = .54).
Percentage change in flow-mediated dilation was linked to percentage change in walking distance (P = .03).
“There is no doubt about the benefits of exercise training on blood vessel health in PAD patients,” Kazuki Hotta, PhD, postdoctoral fellow in engineering science at the University of Electro-Communications in Tokyo, said in the release. “If you have limited walking ability, I recommend that you at least perform muscle stretches so you can gain enough comfort and confidence in walking to participate in a walking exercise program.” – by Darlene Dobkowski
Reference:
Hotta K, et al. Presentation 319. Presented at: American Heart Association’s Arteriosclerosis, Thrombosis and Vascular Biology | Peripheral Vascular Disease Scientific Sessions; May 4-6, 2017; Minneapolis.
Disclosure: The researchers report no relevant financial disclosures.